AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Fiberoptic Intubation in Lateral Versus Supine Position in Pediatrics Undergoing Non-head-and-neck Surgery

RecruitingNAAges 2 Years - 10 YearsAllCairo University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Fiberoptic intubation was first described in the late 1960s and has since become an effective and well-established technique for airway management in awake, sedated, and anesthetized patients. This technique is especially useful in patients with known or suspected difficult airways such as those with limited mouth opening, reduced neck mobility, cervical spine injury, obesity, or an elevated risk for aspiration. The benefits of fiberoptic intubation also include fewer complications such as tooth injury and oropharyngeal bleeding; and the opportunity for optimal positioning of double-lumen tubes in patients undergoing thoracic surgery. Anesthesiologists may be confronted with situations in which patients in a lateral position during surgery experience an accidental loss of airway patency. Intubation with direct laryngoscopy is more challenging and time-consuming in patients in the latera

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Children aged 2-10 years old. * Both genders. * ASA physical status I and II. * Elective non-head-and-neck surgeries. Exclusion Criteria: * Refusal of patients. * Head and neck surgeries or with history of previous ones. * Head, neck and lung congenital deformities or pathologies. * Patients with expected difficult intubation (based on examination). * Patients with neuromuscular disorders. * Hypoxia: defined as low oxygen saturation (SpO2) โ‰ค 95% on room air. * Trauma patients or patients requiring emergency procedures.
๐Ÿ’Š

What it tests

  • Supine position
  • Lateral position
๐Ÿ“

Where

1 site
Faculty of Medicine, Cairo University
Cairo, Egypt
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy